Operating Income (Loss) in USD of Barinthus Biotherapeutics plc. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2020 to Q3 2025.
  • Barinthus Biotherapeutics plc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$15.1M, a 60.6% decline year-over-year.
  • Barinthus Biotherapeutics plc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$82.4M, a 27.6% decline year-over-year.
  • Barinthus Biotherapeutics plc. annual Operating Income (Loss) for 2024 was -$68M, a 19% increase from 2023.
  • Barinthus Biotherapeutics plc. annual Operating Income (Loss) for 2023 was -$83.9M, a 1977% decline from 2022.
  • Barinthus Biotherapeutics plc. annual Operating Income (Loss) for 2022 was -$4.04M, a 91.1% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Barinthus Biotherapeutics plc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$82.4M -$15.1M -$5.69M -60.6% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 -$76.7M -$23.3M -$5.04M -27.6% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$71.7M -$20.6M -$3.69M -21.8% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 -$68M -$23.4M -$3.4M -17% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$64.6M -$9.38M +$6.73M +41.8% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 -$71.3M -$18.3M +$8.05M +30.6% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$79.3M -$16.9M +$4.57M +21.3% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 -$83.9M -$20M +$5.18M +20.6% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$89.1M -$16.1M -$23.3M -323% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 -$65.8M -$26.3M -$39.6M -299% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$26.2M -$21.5M -$22.1M -3385% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$4.04M -$25.2M -$8.5M -51% 01 Oct 2022 31 Dec 2022 10-K 20 Mar 2024
Q3 2022 $4.46M $7.24M +$12.8M 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$8.32M $13.2M +$30.1M 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$38.4M $654K +$6.83M 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$45.2M -$16.7M -$7.04M -73% 01 Oct 2021 31 Dec 2021 10-K 24 Mar 2023
Q3 2021 -$38.2M -$5.54M -$4.11M -288% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$34.1M -$16.8M -$12.5M -288% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$21.6M -$6.17M -$1.52M -32.8% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 -$20M -$9.63M 01 Oct 2020 31 Dec 2020 10-K 25 Mar 2022
Q3 2020 -$1.43M 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$4.34M 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$4.65M 01 Jan 2020 31 Mar 2020 10-Q 14 Jun 2021

Barinthus Biotherapeutics plc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$68M +$15.9M +19% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$83.9M -$79.9M -1977% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$4.04M +$41.2M +91.1% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024
2021 -$45.2M -$25.2M -126% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023
2020 -$20M 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.